Sanofi India Share Price

₹ 3,204.00

+₹1.50 (0.05%)
1D
Last updated 20 Nov, 2026, 15:29 IST
NSE: SANOFI
|
Pharmaceuticals

Sanofi India Share Price Today

As of 22 Nov 2026, Sanofi India share price is ₹3,204.00. The stock opened at ₹3,170.00, compared to its previous close of ₹3,202.50. During today's trading session, Sanofi India share price moved in the range of ₹3,170.00 to ₹3,216.50, with an average price of ₹3,193.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹2,758.20 and a high of ₹4,531.50. On the performance front, Sanofi India share price has increased by 0.50% over the last six months and is down 29.83% on a year-on-year basis.

Share price over the last 1 day rose from 3188.20 to 3204.00, ranging between 3188.00 and 3216.50.

₹3,170.00
0.05% up today
₹3,216.50
1D LOW
1D HIGH

Sanofi India Stock Insights

Latest Earning
Op Profit TrendUp by 8.53% QoQ
Latest Earning
Net Profit TrendUp by 11.07% QoQ
Latest Earning
Revenue TrendDown by 1.05% QoQ
Stock Performance
OutperformingBeat Nifty by 0.3 % in last 1 month
Shareholding Pattern
DIIDII increased stake by 0.50%
Shareholding Pattern
FIIFII increased stake by 0.67%
Sanofi India stock performance
Open₹3,170.00
High₹3,216.50
Low₹3,170.00
Prev. close₹3,202.50
Sanofi India trading activity
Volume8,473
Average traded price₹3,200.30
Last traded time03:29:56 20 Nov
Last traded quantity1

Circuit
L
H
₹2,564.90
₹3,847.30
52-week
L
H
₹2,758.20
₹4,531.50
Mkt Cap Cr
8,111.74

P/E
34.06

P/B
16.36

ROA
46.03%
ROE
47.13%

ROCE
47.95%

Quick Ratio
0.87

EV/EBITDA
24.25

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Sanofi India outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sanofi India appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Sanofi India earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.67
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.03
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.58
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.59
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.48
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sanofi India Company Background

ISIN
INE058A01010
Sector Market Cap
₹ 8,111.74 Cr

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.

Sanofi India Financial Highlights

  • Revenue: Sanofi India reported revenue of ₹2,029.70 crore in FY24 vs ₹2,057.30 crore in FY23. It showed a decrease of 1.34% on a yearly basis.
  • Operating Profit: Sanofi India reported an operating profit of ₹431.40 crore in FY24 vs ₹528.50 crore in FY23. It showed a decrease of 18.37% on a year-on-year basis.
  • Net Profit: Sanofi India reported a net profit of ₹413.30 crore in FY24 vs ₹602.90 crore in FY23. It showed a decrease of 31.45% on a yearly basis.

Sanofi India Quarterly Result Highlights

  • Sanofi India reported revenue of ₹520.80 crore in Dec 2024, compared with ₹526.30 crore in Sep 2024, representing a decrease of 1.05% on a quarter-on-quarter (QoQ) basis.
  • Sanofi India reported an operating profit of ₹122.20 crore in Dec 2024, compared with ₹112.60 crore in Sep 2024, representing an increase of 8.53% on a quarter-on-quarter (QoQ) basis.
  • Sanofi India reported a profit of ₹91.30 crore in Dec 2024, compared with ₹82.20 crore in Sep 2024, reflecting an increase of 11.07% on a QoQ basis.
  • The earnings per share (EPS) of Sanofi India stood at ₹179.46 during Dec 2024.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
60.40%
FII
5.73%
Other DII
10.78%
Retail and other
14.47%
Mutual funds
8.62%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20255.55%
Mar 20265.64%
Jun 20265.69%
Sep 20265.73%

Sanofi India Investment Returns

1 day
+0.11%

1 week
-2.89%

1 month
+11.31%

1 year
-29.83%

3 years
-58.52%

5 years
-60.76%

Sanofi India Share Price History

Sanofi India share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹3,170.00 / ₹3,206.10
+0.11%
19 Nov 26
₹3,245.00 / ₹3,202.50
-0.91%
18 Nov 26
₹3,234.60 / ₹3,231.80
+0.25%
17 Nov 26
₹3,272.00 / ₹3,223.90
-1.77%
Show more

Sanofi India Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsDec 2024Dec 2023
Revenue₹2,013.20₹1,996.10
Other Income₹16.50₹61.20
Total Revenue₹2,029.70₹2,057.30
Total Expenses₹1,560.60₹1,546.60
Profit Before Tax₹431.40₹528.50
Tax₹117.70₹163.90
Profit After Tax₹313.70₹364.60
EPS - Basic₹179.46₹261.78
EPS - Diluted₹179.46₹261.78

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsDec 2024Dec 2023
Profit before tax₹562.40₹845.50
Income before WC changes₹587.50₹820.70
Change in Assets-₹186.60-₹241.80
Change in Liabilities₹158.00-₹107.20
Change in WC-₹28.60-₹349.00
Cash flow from Operations₹461.50₹230.40
Cash flow from Investing-₹19.20₹37.50
Cash flow from Financing-₹392.40-₹878.30
Total Cash Flow₹49.90-₹610.40
Cash (Start of the year)₹394.50₹1,004.90
Cash (End of the year)₹283.80₹394.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsDec 2024Dec 2023
Non-Current Assets₹485.00₹466.80
Current Assets₹1,126.80₹1,248.00
Total Assets₹1,611.80₹1,714.80
Current Liabilities₹719.20₹651.30
Net Current Asset₹407.60₹596.70
Non-Current Liabilities₹32.00₹48.30
Equity Capital₹860.60₹1,015.20
Total Equity & Liabilities₹1,611.80₹1,714.80

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023Dec 2022
Revenue₹1,837.40₹2,013.20₹2,851.10₹2,770.10
Other Income₹19.70₹16.50₹65.30₹71.50
Total Revenue₹1,857.10₹2,029.70₹2,916.40₹2,841.60
Total Expenses₹1,385.10₹1,560.60₹2,088.40₹2,109.30
Profit Before Tax₹444.70₹431.40₹845.80₹864.30
Tax₹118.00₹117.70₹242.60₹243.70
Profit After Tax₹326.70₹313.70₹603.20₹620.60
EPS - Basic₹141.85₹179.54₹261.91₹269.47
EPS - Diluted₹141.85₹179.54₹261.91₹269.47

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023Dec 2022
Profit before tax₹444.70₹562.60₹845.80₹864.30
Income before WC changes₹473.50₹587.70₹821.00₹705.00
Change in Assets₹310.90-₹186.60-₹241.70-₹16.50
Change in Liabilities-₹239.30₹158.00-₹107.20-₹29.10
Change in WC₹71.60-₹28.60-₹348.90-₹45.60
Cash flow from Operations₹438.30₹461.70₹230.80₹398.70
Cash flow from Investing-₹11.30-₹19.20₹35.50₹650.90
Cash flow from Financing-₹447.90-₹392.40-₹878.30-₹1,582.70
Total Cash Flow-₹20.90₹50.10-₹612.00-₹533.10
Cash (Start of the year)₹283.80₹392.90₹1,004.90₹1,538.00
Cash (End of the year)₹262.90₹283.80₹392.90₹1,004.90

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsDec 2025Dec 2024Dec 2023Dec 2022
Non-Current Assets₹454.20₹485.00₹468.80₹461.40
Current Assets₹800.60₹1,126.80₹1,246.30₹1,610.30
Total Assets₹1,254.80₹1,611.80₹1,715.10₹2,071.70
Current Liabilities₹491.40₹736.50₹651.30₹740.60
Net Current Asset₹309.20₹390.30₹595.00₹869.70
Non-Current Liabilities₹14.20₹14.70₹48.30₹55.30
Equity Capital₹749.20₹860.60₹1,015.50₹1,275.80
Total Equity & Liabilities₹1,254.80₹1,611.80₹1,715.10₹2,071.70
* All values are in INR Crore
Sanofi India market depth
Bid quantityBid priceAsk priceAsk quantity
003206.113
0000
0000
0000
0000
Total bid quantity0
Total ask quantity13
Sanofi India technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
51.05
Neutral

ATR (14)
65.84
Neutral

STOCH(9,6)
18.72
Bullish

STOCH RSI (14)
1.37
Bullish

ADX(9)
27.62
Bearish

UO(9)
43.46
Neutral

ROC(12)
-7.09
Bearish

WillR(14)
-87.76
Bullish
Period
Simple value
Exponential vaue

5D
3229.24
3228.54

10D
3266.65
3242.97

20D
3241.05
3215.16

50D
3107.18
3170.67

100D
3210.82
3199.78
Volume trend — traded volume by day
20 Nov0L
19 Nov0L
18 Nov0L
17 Nov0L
16 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Sanofi India
Pharmaceuticals
Add Stock
Add Another

Sanofi India Returns Calculator

Ex-date: 05 Nov 2026

Ex-date: 22 Apr 2026

Sanofi India Latest News

1 month ago
Stocks to watch, Sept 25: PB Fintech, SAIL, Sedemac Mechatronics, Dr Lal Pathlabs, Genesys International, Wheels India
3 months ago
TVS Holdings announces ₹86 per share dividend, sets record date; Sanofi India fixes record date; check details
Showing news item 1 of 2

Sanofi India Share Price FAQs












Please be aware that Sanofi India stock prices are subject to continuous fluctuations due to various factors.